Walstad R A, Blika S
Scand J Infect Dis Suppl. 1985;44:63-7.
The penetration of ceftazidime into the aqueous humour and the vitreous body of the rabbit eye, after intravenous (i.v.) bolus or subconjunctival injection, was investigated. A dose of 50 mg/kg body weight was administered. After i.v. administration the mean penetration into the aqueous humour was 13% of the plasma values. After subconjunctival injection into the left eye, mean levels of 14% and 25% of the plasma concentrations were found in the right and left eye, respectively. The concentrations in the vitreous body were in all cases below the ceftazidime detection limit (1 mg/l), i.e. less than 1% of the plasma levels. The mean penetration of ceftazidime into human aqueous humour (measured during cataract extraction) was 19% after 2 g i.v. bolus injection. Ceftazidime levels sufficient to inhibit the growth of most pathogens commonly responsible for intraocular infections, including Pseudomonas spp., were consistently found in the aqueous humour. However, inadequate concentrations were achieved in the vitreous body.
研究了静脉推注或结膜下注射后,头孢他啶在兔眼房水和玻璃体中的渗透情况。给予50mg/kg体重的剂量。静脉给药后,房水的平均渗透量为血浆值的13%。左眼结膜下注射后,右眼和左眼的平均水平分别为血浆浓度的14%和25%。玻璃体中的浓度在所有情况下均低于头孢他啶检测限(1mg/l),即低于血浆水平的1%。静脉推注2g后,头孢他啶在人房水中的平均渗透量(白内障摘除术中测量)为19%。在房水中一直发现有足以抑制包括假单胞菌属在内的大多数常见眼内感染病原体生长的头孢他啶水平。然而,玻璃体中达到的浓度不足。